Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kazumitsu Kanatani"'
Autor:
Hiroji Iwata, Masaya Hattori, Emi Noguchi, Nobuaki Sato, Jun Horiguchi, Kazumitsu Kanatani, Yasuhiro Fujiwara, Kiyoshi Matsunaga, Kenji Tamura
Publikováno v:
Breast Cancer. 26:39-46
To investigate the safety, pharmacokinetics, and efficacy of trastuzumab emtansine (T-DM1) in combination with pertuzumab in Japanese patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. Patients with HER2-
Autor:
Kosei Tajima, Nobuaki Sato, Norikazu Masuda, Takahiro Nakayama, Kazuhiko Nakagami, Yasuhiro Okumura, Kazumitsu Kanatani, Masahiro Kashiwaba, Masato Takahashi
Publikováno v:
Japanese Journal of Clinical Oncology. 47:385-392
Background In the double-blind placebo-controlled randomized Phase III MERiDiAN trial (ClinicalTrials.gov NCT01663727), adding bevacizumab to paclitaxel for HER2-negative metastatic breast cancer (mBC) significantly improved progression-free survival
Autor:
Masahiro Kashiwaba, Hiroyoshi Doihara, Yoshiaki Rai, Kazumitsu Kanatani, Shintaro Takao, Yoshinori Ito, Shigemitsu Takashima, Norikazu Masuda
Publikováno v:
Japanese Journal of Clinical Oncology. 46:407-414
Objective Trastuzumab emtansine significantly improved progression-free survival and overall survival when compared with lapatinib-capecitabine in pretreated human epidermal growth factor receptor 2-positive advanced breast cancer. However, data in J
Autor:
Koichiro Tsugawa, Shintaro Nakagawa, Shintaro Takao, Takahiro Nakayama, Yoshinori Ito, Kazuhiko Nakagami, Junichiro Watanabe, Toshimi Takano, Toshiaki Saeki, Kazumitsu Kanatani, Norikazu Masuda
Background/aim Tolerability and safety of trastuzumab emtansine (T-DM1) was investigated in Japanese patients with HER2-positive advanced breast cancer who were previously treated with chemotherapy and trastuzumab. Patients and methods Patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecbdb28e7daccc908199a46d92668e6
https://europepmc.org/articles/PMC5461466/
https://europepmc.org/articles/PMC5461466/
Autor:
Tomohisa Ishikawa, Kazumitsu Kanatani, Yukiko Kaneko, Fumi Sugino, Kazuo Obara, Koichi Nakayama, Eri Iwasaki
Publikováno v:
Life Sciences. 77:462-469
The roles of protein kinase C (PKC) isoforms in cholinergic potentiation of glucose-induced insulin secretion were investigated in rat pancreatic islets. Western-blot analysis showed the presence of PKC-alpha, betaII, delta, epsilon, eta, and zeta, b
Autor:
Hidetaka Tsuda, Miki Takii, Takaaki Sunouchi, Tomohisa Ishikawa, Koichi Nakayama, Yukiko Kaneko, Kazumitsu Kanatani
Publikováno v:
American journal of physiology. Cell physiology. 291(6)
In isolated rat pancreatic β-cells, hypotonic stimulation elicited an increase in cytosolic Ca2+ concentration ([Ca2+]c) at 2.8 mM glucose. The hypotonically induced [Ca2+]c elevation was significantly suppressed by nicardipine, a voltage-dependent
Autor:
Norikazu Masuda, Masato Takahashi, Kazuhiko Nakagami, Yasuhiro Okumura, Takahiro Nakayama, Nobuaki Sato, Kazumitsu Kanatani, Kosei Tajima, Masahiro Kashiwaba
Publikováno v:
Japanese Journal of Clinical Oncology; May2017, Vol. 47 Issue 5, p385-392, 8p
Autor:
Shintaro Takao, M. Matsubara, Kazumitsu Kanatani, Masahiro Kashiwaba, Hiroyoshi Doihara, Noriyuki Masuda, S. Takahashi, Yoshiaki Rai, Yoshinori Ito
Publikováno v:
Annals of Oncology. 24:ix20